Diet-induced Obesity in Sprague-Dawley Rats Causes Microvascular and Neural Dysfunction
Overview
Affiliations
Background: The objective of this study was to determine the effect of diet-induced obesity (DIO) on microvascular and neural function.
Methods: Rats were fed a standard or high fat diet for up to 32 weeks. The following measurements were carried out: vasodilation in epineurial arterioles using videomicroscopy, endoneurial blood flow using hydrogen clearance, nerve conduction velocity using electrical stimulation, size-frequency distribution of myelinated fibres of the sciatic nerve, intraepidermal nerve fibre density using confocal microscopy and thermal nociception using the Hargreaves method.
Results: Rats fed a high fat diet for 32 weeks developed sensory neuropathy, as indicated by slowing of sensory nerve conduction velocity and thermal hypoalgesia. Motor nerve conduction velocity and endoneurial blood flow were not impaired. Mean axonal diameter of myelinated fibres of the sciatic nerve was unchanged in high fat-fed rats compared with that in control. Intraepidermal nerve fibre density was significantly reduced in high fat-fed rats. Vascular relaxation to acetylcholine and calcitonin gene-related peptide was decreased and expression of neutral endopeptidase (NEP) increased in epineurial arterioles of rats fed a high fat diet. In contrast, insulin-mediated vascular relaxation was increased in epineurial arterioles. NEP activity was significantly increased in the skin of the hindpaw. Markers of oxidative stress were increased in the aorta and serum of high fat-fed rats but not in epineurial arterioles.
Conclusion: Chronic obesity causes microvascular and neural dysfunction. This is associated with increased expression of NEP but not oxidative stress in epineurial arterioles. NEP degrades vasoactive peptides, which may explain the decrease in microvascular function.
Ivanova N, Hristov M, Gateva P Int J Mol Sci. 2025; 26(5).
PMID: 40076715 PMC: 11899846. DOI: 10.3390/ijms26052094.
Obrosov A, Coppey L, Shevalye H, Yorek M J Diabet Complicat Ther. 2023; 1(1).
PMID: 37332358 PMC: 10274354.
The conundrum of diabetic neuropathies-Past, present, and future.
Ang L, Mizokami-Stout K, Eid S, Elafros M, Callaghan B, Feldman E J Diabetes Complications. 2022; 36(11):108334.
PMID: 36306721 PMC: 10202025. DOI: 10.1016/j.jdiacomp.2022.108334.
Advances in diet-induced rodent models of metabolically acquired peripheral neuropathy.
Eid S, Feldman E Dis Model Mech. 2021; 14(11).
PMID: 34762126 PMC: 8592018. DOI: 10.1242/dmm.049337.
Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy.
Sloan G, Selvarajah D, Tesfaye S Nat Rev Endocrinol. 2021; 17(7):400-420.
PMID: 34050323 DOI: 10.1038/s41574-021-00496-z.